Insurance

Prostate Cancer drugs cost more in the USA than in other countries.

The cost of Enzalutamide (Xtandi) in the United States is being challenged by Knowledge Ecology International (KEI), a public interest advocacy group. The average US wholesale price of Xtandi in 2015 was $88 per capsule. That can add up to $129,000 annual cost per man. There are significant issues related to high costs of treatment. [...]

By Malecare|2021-02-17T10:41:27-05:00May 5th, 2016|Advanced Prostate Cancer, Advocacy, Disparities, Drugs & Treatments, enzalutamide, Insurance, NIH, Politics of Cancer, Uncategorized, United States, Xtandi|0 Comments

Of Interest In the News – Surprise Out-of Network Bills and the U.S. Preventive Task Force Becomes Controversial

In an article in Time (3/7 Sweetland Edwards) there is a discussion about the failure of the Affordable Care Act to stop patients from receiving “surprise” bills from their medical providers for services provided. These surprises result from people going to a medical facility, which is in their Network but having some service, provided by [...]

By Malecare|2020-02-04T12:41:14-05:00March 9th, 2016|